RTTNews | Oct 15, 2020 07:53AM EDT

07:52 Thursday, October 15, 2020 (RTTNews.com) - Covis Group S. r.l. announced the commencement of a cash tender offer to purchase all of the outstanding shares of common stock of AMAG Pharmaceuticals, Inc. (AMAG). The deal has a total enterprise value of approximately $647 million, including net debt. The tender offer will expire on November 12, 2020.

Covis is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It is headquartered in Luxembourg with operations in Zug, Switzerland.

Read the original article on RTTNews ( https://www.rttnews.com/3136456/covis-announces-commencement-of-13-75-shr-tender-offer-to-acquire-amag-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved